Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as President and Chief Operating Officer. Dr. Manion will be responsible for overseeing day-to-day operations, continuing to develop Aclaris’ infrastructure and helping Aclaris develop its vision and overall strategic direction alongside Neal Walker, Aclaris’ CEO, and Aclaris’ board of directors.Read more
Celebrate Your Team. Celebrate Their Success.
Showcase your company’s growth by promoting your new hires and recent promotions to the BioBuzz audience.
Take a Minute to Learn More About the Most Recent POTM
Submit your People on the Move
Share your pride for a new hire, promotion, or career accomplishment. Keeps your team front and center and create buzz around your company as a great place to work.Submit Today